home / stock / cdxi / cdxi short
Short Information | Cardax Inc (OTCMKTS:CDXI)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 19,141 |
Total Actual Volume | 61,548 |
Short Trends | |
---|---|
Cover Days | 7 |
Short Days | 13 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 957 |
Average Short Percentage | 58.03% |
Is there a CDXI Short Squeeze or Breakout about to happen?
See the CDXI Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-06-2022 | $0.45 | $0.43 | $0.45 | $0.43 | 478 | 239 | 50% |
04-25-2022 | $1 | $1 | $1 | $1 | 800 | 600 | 75% |
02-04-2022 | $1 | $0.8 | $1 | $0.8 | 1,299 | 1,099 | 84.6% |
02-01-2022 | $1.45 | $1.4001 | $1.45 | $1.4 | 2,560 | 200 | 7.81% |
01-21-2022 | $0.55 | $0.2 | $0.55 | $0.2 | 43,154 | 12,500 | 28.97% |
12-02-2021 | $1 | $1 | $1.1 | $1 | 2,200 | 200 | 9.09% |
12-01-2021 | $1 | $1 | $1 | $1 | 120 | 100 | 83.33% |
11-29-2021 | $0.65 | $0.65 | $0.65 | $0.65 | 540 | 300 | 55.56% |
10-13-2021 | $1 | $1 | $1 | $1 | 122 | 100 | 81.97% |
09-27-2021 | $1 | $1 | $1 | $1 | 100 | 100 | 100% |
09-21-2021 | $1 | $1 | $1 | $1 | 340 | 100 | 29.41% |
09-07-2021 | $1.3 | $1.3 | $1.3 | $1.3 | 1,100 | 1,000 | 90.91% |
08-09-2021 | $1.4 | $1.4 | $1.4 | $1.4 | 400 | 100 | 25% |
06-30-2021 | $1.5 | $1.49 | $1.5 | $1.49 | 1,500 | 1,384 | 92.27% |
05-17-2021 | $1.75 | $1.75 | $1.75 | $1.75 | 180 | 100 | 55.56% |
01-28-2021 | $1.7701 | $1.7701 | $1.7701 | $1.7701 | 2,302 | 27 | 1.17% |
01-27-2021 | $1.7 | $1.77 | $6 | $1.7 | 3,441 | 145 | 4.21% |
01-19-2021 | $1.6 | $1.6 | $1.6 | $1.6 | 608 | 554 | 91.12% |
01-11-2021 | $1.6 | $1.6 | $1.6 | $1.6 | 204 | 193 | 94.61% |
01-04-2021 | $1.7 | $1.7 | $1.7 | $1.7 | 100 | 100 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Cardax Voluntarily Suspends SEC Reporting Obligations Expected savings to support core business strategies PR Newswire HONOLULU , Aug. 11, 2021 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) announced today the filing of a Form 15 with the U.S. Securities and...
Cardax Reports Q1 2021 Results - Operating loss decreased vs. Q1 2020 - Net loss increased vs. Q1 2020 - ZanthoSyn® revenues decreased vs. Q1 2020 - Company pursuing multiple funding opportunities PR Newswire HONOLULU , May 14, 2021 /PRNewswi...
Cardax Reports 2020 Results - Net loss and operating expenses decreased vs. 2019 - ZanthoSyn® revenues decreased vs. 2019 - Company pursuing multiple funding opportunities - CHASE study recruitment suspended due to COVID-19 - COVID-19 clinical trial grant ap...